| HealthPartners | Recent Food and Drug Administration (FDA) approved | 2025-07-01 |
| HealthPartners | Romosozumab-aqqg (Evenity®) | 2025-07-01 |
| HealthPartners | Romosozumab-aqqg (Evenity®) – Minnesota Health | 2025-07-01 |
| HealthPartners | Somatostatin analogues for acromegaly (Sandostatin | 2025-07-01 |
| HealthPartners | Third party payments | 2025-07-01 |
| HealthPartners | Tofersen (Qalsody™) | 2025-07-01 |
| Ambetter Health Illinois Clinical | Intradiscal Steroid Injections for Pain Management | 2025-07-01 |
| Ambetter Health Illinois Clinical | Sacroiliac Joint Interventions for Pain Management | 2025-07-01 |
| Ambetter Health Michigan Meridian Clinical | Sacroiliac Joint Interventions for Pain Management | 2025-07-01 |
| Sentara Health Plans | Ambulatory Devices, DME 40 - Commercial | 2025-07-01 |